Where Oxford AI startups raise capital in 2026

15 investors are backing Oxford AI startups in 2026. Amadeus Capital and Oxford Science Enterprises led Stateful Robotics' $4.8M pre-seed in March 2026. Parkwalk and IP Group extended Brainomix's Series C to £18.8M in February 2026. UK AI investment hit £8.3B in 2025.

Oxford is home to the UK's first AI Growth Zone at Culham. Oxfordshire spinouts raised £2.6B in 2025, a 38% increase from the previous year. University of Oxford leads all UK universities in spinout formation.

Oxford AI founders benefit from access to world-class research across the Department of Engineering Science, the Future of Humanity Institute, and the Oxford Internet Institute. Investors know that.

Don't pitch without a working prototype and a clear commercialisation path. Oxford AI investors expect technical depth. Wrappers around foundation models won't attract serious capital.

Set up an Ellty data room with your technical architecture, IP documentation, and financial model before any first contact. Oxford AI investors ask for technical materials within 48 hours.

What is an Oxford AI investor?

Oxford AI investors back companies built on machine learning, computer vision, NLP, or AI hardware research tied to the University of Oxford. They differ from generalist VCs by evaluating technical defensibility before commercial traction.

Oxford AI spinouts benefit from research anchors in the Department of Engineering Science, the Oxford Internet Institute, and the Turing Institute. Investors know which labs produce defensible IP and which don't.

Check sizes range from pre-seed at Longwall Ventures and Oxford Capital to multi-million Series A and B from Amadeus Capital Partners, IQ Capital, and OSE. British Patient Capital and BGF cover growth-stage Oxford AI companies.

See how London AI investors differ in deal flow and stage preference. Many Oxford AI founders raise from Oxford-based VCs first, then bring in London-based growth investors at Series A and beyond.

15 Oxford AI investors

1. Oxford Science Enterprises

Oxford Science Enterprises is a £1.1B investment company backing University of Oxford spinouts from seed to growth. They co-led Stateful Robotics' $4.8M pre-seed alongside Amadeus Capital in March 2026. In 2025, OSE backed Ultromics (€48M), Scripta Therapeutics (€10M+), and Wild Bioscience (€51M). OSE backed 11 companies in 2025 and 2 in the first six weeks of 2026.

Set up an Ellty data room with your technical architecture, Oxford IP licence, and financial model before approaching OSE. Their investment team requests materials within 48 hours of first contact.

• Recent Deals: Stateful Robotics $4.8M pre-seed lead (March 2026); Ultromics €48M (2025); Scripta Therapeutics €10M+ (2025); 11 investments in 2025
• LinkedIn: Oxford Science Enterprises LinkedIn
• Sector Focus: AI, deep tech, life sciences, health tech
• Stage Focus: Seed to growth
• Location: Oxford, UK
• Website: oxfordscienceenterprises.com

2. Amadeus Capital Partners

Amadeus Capital Partners manages $1.3B+ and co-led Stateful Robotics' $4.8M pre-seed alongside OSE in March 2026. They have a dedicated AI investment track ("Intelligence") covering AI, advanced computing, and quantum. Their AI portfolio includes PolyAI ($86M Series D, December 2025) and Unlikely AI. Amadeus is co-founded by Hermann Hauser, the ARM co-founder, and backs Oxford AI founders at seed and Series A.

• Recent Deals: Stateful Robotics $4.8M pre-seed co-lead (March 2026); PolyAI $86M Series D (December 2025); Unlikely AI portfolio; $1.3B+ AUM
• LinkedIn: Amadeus Capital Partners LinkedIn
• Sector Focus: AI, robotics, quantum, advanced computing
• Stage Focus: Seed to Series C
• Location: Cambridge and London
• Website: amadeuscapital.com

3. IP Group

IP Group is a university spinout investor managing Parkwalk Advisors (acquired 2017) and the IP Group Hostplus Innovation Fund. They backed Brainomix's £4.8M Series C extension via the Hostplus Innovation Fund in February 2026. IP Group has backed Lumai ($10M+, April 2025) and has deep Oxford AI exposure across their portfolio. They are a structural long-term investor in the Oxford AI ecosystem.

• Recent Deals: Brainomix £4.8M Series C extension (February 2026); Lumai $10M+ (April 2025); IP Group Hostplus Innovation Fund active; Oxford deep tech portfolio
• LinkedIn: IP Group LinkedIn
• Sector Focus: Oxford AI, deep tech, life sciences
• Stage Focus: Seed to growth
• Location: London with Oxford focus
• Website: ipgroupplc.com

4. Parkwalk Advisors

Parkwalk Advisors manages £450M+ in EIS funds backing UK university spinouts. They led Brainomix's £4.8M Series C extension in February 2026 alongside IP Group. Parkwalk co-invests with OSE and Longwall Ventures on Oxford AI spinout rounds. They are the most tax-efficient route for Oxford AI founders targeting angel and EIS investors at seed stage.

• Recent Deals: Brainomix £4.8M Series C extension lead (February 2026); 41 spinout deals in 2024; £450M+ AUM; Oxford AI EIS mandate
• LinkedIn: Parkwalk Advisors LinkedIn
• Sector Focus: Oxford AI spinouts, EIS, life sciences, deep tech
• Stage Focus: Pre-seed to Series B
• Location: London with Oxford focus
• Website: parkwalk.vc

5. Longwall Ventures

Longwall Ventures backs early-stage Oxford spinouts in AI and deep tech alongside OSE and Oxford Technology Management. They are the most active seed-stage co-investor in the OSE network and participated in the June 2026 Oxford Venture Tour. Longwall bridges pre-seed Oxford AI founders from idea stage to OSE and Parkwalk Series A.

• Recent Deals: Caristo £16.3M Series A (with OSE and BGF); June 2026 Oxford Venture Tour participant; Oxford AI and deep tech seed mandate
• LinkedIn: Longwall Ventures LinkedIn
• Sector Focus: Oxford AI, deep tech, life sciences spinouts
• Stage Focus: Seed to Series A
• Location: Oxford, UK
• Website: longwall.vc

6. Oxford Capital

Oxford Capital runs EIS and SEIS funds focused on Oxford-area AI and technology companies. They backed NavLive's £4M round in May 2025 alongside University of Oxford. Oxford Capital is the primary EIS fund for Oxford AI founders who need capital with a local institutional backer before OSE and Amadeus can lead. They co-invest with Longwall Ventures and OSE at seed stage.

Upload your Oxford AI pitch to Ellty and share it with Oxford Capital before any first meeting. Track which sections they spend time on before following up.

• Recent Deals: NavLive £4M (May 2025); Oxford-area EIS/SEIS fund active 2025-2026; Oxford AI and tech spinout focus
• LinkedIn: Oxford Capital LinkedIn
• Sector Focus: Oxford AI, tech spinouts, EIS
• Stage Focus: Seed to Series A
• Location: Oxford, UK
• Website: oxcp.com

7. Constructor Capital

Constructor Capital led Lumai's $10M+ seed in April 2025, an Oxford AI accelerator startup using optical computing to cut AI inference costs. They focus on visionary founders in deep tech and AI hardware. Constructor Capital is the best European VC contact for Oxford founders building AI infrastructure - optical computing, neuromorphic chips, or novel inference architectures.

• Recent Deals: Lumai $10M+ seed lead (April 2025); AI hardware and deep tech focus; Oxford University spinout mandate
• LinkedIn: Constructor Capital LinkedIn
• Sector Focus: AI hardware, optical computing, deep tech
• Stage Focus: Seed to Series A
• Location: Europe
• Website: constructor.capital

8. IQ Capital

IQ Capital manages $1B+ and is Cambridge's most active deep tech VC with a dedicated AI investment track. They back Oxford and Cambridge AI companies alike. IQ Capital focuses on AI at the hardware edge - robotics, semiconductors, and AI systems. Oxford AI founders building technical infrastructure products should approach IQ Capital alongside Amadeus and OSE.

• Recent Deals: Nu Quantum $60M Series A co-lead (December 2025); Fund V BBB £50M cornerstone (January 2026); $1B+ AUM; Oxford and Cambridge AI mandate
• LinkedIn: IQ Capital LinkedIn
• Sector Focus: AI, robotics, semiconductors, quantum
• Stage Focus: Seed to Series A + growth
• Location: Cambridge and London
• Website: iqcapital.vc

9. Molten Ventures

Molten Ventures backs early-stage European AI and B2B software companies at seed and Series A. They co-invest with Amadeus on Oxford rounds and back AI SaaS, data infrastructure, and applied AI. Oxford AI founders building enterprise software products should approach Molten alongside Balderton Capital.

Read about best fundraising software for startups before running a multi-investor Oxford AI raise. Managing 4+ simultaneous processes requires organised pipeline tracking.

• Recent Deals: European AI and SaaS mandate; Amadeus co-investment history; seed to Series A focus; active 2025-2026
• LinkedIn: Molten Ventures LinkedIn
• Sector Focus: AI SaaS, B2B AI, data infrastructure
• Stage Focus: Seed to Series A
• Location: London
• Website: moltenventures.com

10. Octopus Ventures

Octopus Ventures made 18 investments in 2025 with a dedicated deep tech pre-seed fund. They back Oxford AI companies in healthcare AI, applied AI, and enterprise automation. Octopus is one of the most active UK investors in AI health companies, which aligns directly with Oxford's AI-enabled diagnostics spinout pipeline.

• Recent Deals: 18 investments in 2025; Infinitopes (January 2026); deep tech pre-seed fund; healthcare AI mandate
• LinkedIn: Octopus Ventures LinkedIn
• Sector Focus: AI health, B2B AI, applied AI
• Stage Focus: Pre-seed to growth
• Location: London
• Website: octopusventures.com

11. Balderton Capital

Balderton Capital is one of Europe's most active Series A and B VCs with 14 investments in 2026 as of June. They back AI infrastructure and enterprise AI companies at seed to Series B. Oxford AI founders building globally ambitious products with technical depth should include Balderton alongside Amadeus and IQ Capital for their Series A.

• Recent Deals: Tilt Series A (June 2026); Primer (2026); 14 investments in 2026; AI and enterprise software focus
• LinkedIn: Balderton Capital LinkedIn
• Sector Focus: AI infrastructure, enterprise AI, deep tech
• Stage Focus: Seed to Series B
• Location: London
• Website: balderton.com

12. Sure Valley Ventures

Sure Valley Ventures is a specialist AI and software VC that co-led Astut's £1.6M seed alongside East X Ventures in October 2025. Astut is an Oxford University mathematics spinout building explainable AI. Sure Valley backs UK-wide AI companies at seed and Series A. They are one of the few funds that specifically targets UK explainable AI and trustworthy AI companies.

• Recent Deals: Astut £1.6M seed co-lead (October 2025); AI and software focus; UK-wide seed and Series A mandate
• LinkedIn: Sure Valley Ventures LinkedIn
• Sector Focus: AI, software, UK-wide
• Stage Focus: Seed to Series A
• Location: London and Dublin
• Website: surevalleyventures.com

13. UK Innovation and Science Seed Fund (UKI2S)

UKI2S is a government-backed seed fund specifically targeting UK university AI spinouts. They co-invested in Astut's £1.6M seed in October 2025 alongside Sure Valley Ventures. UKI2S backs Oxford University spinouts that other VCs won't fund at pre-seed. They are the most accessible first capital for Oxford AI founders without commercial traction.

• Recent Deals: Astut £1.6M seed (October 2025); UK university spinout mandate; pre-seed AI focus
• LinkedIn: UKI2S LinkedIn
• Sector Focus: UK university AI spinouts, pre-seed
• Stage Focus: Pre-seed
• Location: UK-wide including Oxford
• Website: ukinnovationscienceseedfund.co.uk

14. BGF

BGF is the most active growth equity investor in the UK and Ireland. They co-invested in Caristo's £16.3M Series A alongside OSE and Longwall Ventures. BGF backs Oxford AI companies past seed with £3M to £30M growth equity checks. Oxford AI founders with early commercial traction and Series A+ goals should approach BGF alongside Molten Ventures.

• Recent Deals: Caristo £16.3M Series A (with OSE and Longwall); most active UK growth equity investor; Oxford AI scale-up mandate
• LinkedIn: BGF LinkedIn
• Sector Focus: AI scale-ups, UK-wide growth equity
• Stage Focus: Series A and beyond
• Location: UK-wide with Oxford coverage
• Website: bgf.co.uk

15. British Patient Capital

British Patient Capital is a £2.5B+ government-backed fund of funds investing in UK AI scale-ups. They backed OMass Therapeutics' drug discovery platform. BPC provides LP capital to leading AI-focused VCs including Amadeus, IQ Capital, and OSE. Oxford AI founders benefit from BPC's support of the UK VC ecosystem at every stage of their fundraising journey.

• Recent Deals: OMass Therapeutics portfolio; £2.5B+ AUM; LP mandate in UK AI and deep tech VCs; active 2025-2026
• LinkedIn: British Patient Capital LinkedIn
• Sector Focus: UK AI and deep tech scale-ups (via fund of funds)
• Stage Focus: Growth (LP and direct)
• Location: London with UK-wide mandate
• Website: british-patient-capital.co.uk

How Oxford AI evaluates technical due diligence

Oxford AI investors look for defensible technical differentiation first. A product built on OpenAI's API with no proprietary data or model layer won't attract serious Oxford VC attention. You need an actual technical moat.

Amadeus and OSE both bring in domain experts before any term sheet. Expect a 2-3 week technical review period where your architecture, training data provenance, and IP ownership are evaluated independently.

Most Oxford AI investors also check whether your core research is publishable or already published. A peer-reviewed paper in NeurIPS or ICML signals genuine technical credibility. Conference publications from Oxford's CS department carry weight.

Use Ellty to share your technical documentation with investors during the review period. Track who opens your model architecture and ablation study sections - that's the signal of genuine technical interest.

Where Oxford AI founders find investors

The Oxford Venture Tour (June 11, 2026) is the single best event for meeting OSE, Longwall Ventures, Oxford Technology Management, and Oxford Capital in one session. Applications open in April each year.

Oxbridge AI X is an acceleration programme for startups from Oxford, Cambridge, and Imperial. Winners receive funding and direct introductions to Amadeus Capital and IQ Capital partners.

The Oxford Internet Institute, Turing Institute, and Department of Engineering Science all host investor events. OSE and Parkwalk send partners to these events and prioritise founders they meet in person.

How to approach Oxford AI investors with cold outreach

OSE accepts applications via oxfordscienceenterprises.com. They review all submissions within three weeks and move fast on companies with clear University of Oxford IP. Don't apply without resolving your IP licence first.

Amadeus Capital runs an annual 'Intelligence Forum' where Oxford AI companies present to partners. Cold email to Amadeus partners with specific technical context about your AI architecture converts better than generic outreach.

UKI2S accepts direct applications from any Oxford University spinout at pre-seed. They are the fastest route to first capital for Oxford AI founders who haven't yet raised anything. Approval timelines are typically 4-6 weeks.

Read the best investor relations software guide before managing simultaneous outreach to Oxford AI VCs. Tracking responses across OSE, Amadeus, Parkwalk, and IQ Capital simultaneously requires a structured process.